Citations

Clear

7551 citation(s) found for "Ho, Matthew".

Extensor Digitorum Brevis Flap for the Coverage of Ankle and Dorsal Foot Wounds: A Technical Trick
Wagner, Eric R. , Pensy, Raymond A., Eglseder, W. Andrew , Houdek, Matthew T. , Wagner, Eric R

Mayo Clinic

Journal of Orthopaedic Trauma | July 7, 2016 | Volume: 30 | Issue: 12 | Pages: e404-e408

10.1097/bot.0000000000000650 | PMID 27392161 Get It

Summary: Soft tissue wounds overlying the dorsum of the foot and ankle are difficult to treat, and historically have been treated with free tissue transfer. Advances in surgical technique have expanded the use of pedicle perforator flaps to avoid free tissue transfer in certain situations. The authors describe a technique for using an extensor digitorum brevis flap to provide soft tissue coverage for wounds of the ankle and foot. In the senior authors’ experience, the use of this flap has achieved wound coverage in 100% of patients with smaller wounds (≤45 cm2) of the ankle.
Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures
Myslinski, Rachel, Miller, Amy S., Francisco, Melissa, Desai, Sonali , Schmajuk, Gabriela , Barber, Claire , Orozco, Catalina, Bunyard, Matthew, Bergman, Martin , Passo, Murray H., Matteson, Eric L. , Olson, Richard D. , Silverman, Stuart L. , Warren, Robert W. , Nola, Kamala , Yazdany, Jinoos , Lacaille, Diane V. , Robbins, Mark L. , Barber, Claire E H

Mayo Clinic

Arthritis Care & Research | July 7, 2016 | Volume: 68 | Issue: 10 | Pages: 1402-1409

10.1002/acr.22985 | PMID 27390129 Get It

Functional and oncologic outcome of cemented endoprosthesis for malignant proximal femoral tumors
Watts, Chad D. , Rose, Peter S. , Taunton, Michael J. , Sim, Franklin H. , Wyles, Cody C. , Houdek, Matthew T. , Taunton, Michael J , Pagnano, Mark W

Mayo Clinic

Journal of Surgical Oncology | June 29, 2016 | Volume: 114 | Issue: 4 | Pages: 501-506

10.1002/jso.24339 | PMID 27353406 Get It

Race or Resource? BMI, Race, and Other Social Factors as Risk Factors for Interlimb Differences among Overweight Breast Cancer Survivors with Lymphedema
Dean, Lorraine T. , Kumar, Anagha , Herling, Matthew, Zhang, Zi , Evangelisti, M. I., Hackley, Renata, Troxel, Andrea B. , Schwartz, J. Sanford, Schmitz, Kathryn H. , Kim, Tae‐Hoon , Brown, Justin C. , Kim, Jiyoung , Cheville, Andrea , Schmitz, Kathryn H

Mayo Clinic

Journal of Obesity | June 29, 2016 | Volume: 2016 | Issue: No issue available | Pages: 1-9

10.1155/2016/8241710 | PMID 27433356 Get It

Introduction. High BMI is a risk factor for upper body breast cancer-related lymphedema (BCRL) onset. Black cancer survivors are more likely to have high BMI than White cancer survivors. While observational analyses suggest up to 2.2 times increased risk of BCRL onset for Black breast cancer survivors, no studies have explored race or other social factors that may affect BCRL severity, operationalized by interlimb volume difference (ILD).Materials and Methods. ILD was measured by perometry for 296 overweight (25 > BMI < 50) Black (n=102) or White (n=194) breast cancer survivors (>6 months from treatment) in the WISER Survivor trial. Multivariable linear regression examined associations between social and physical factors and ILD.Results. Neither Black race (−0.26,p=0.89) nor BMI (0.22,p=0.10) was associated with ILD. Attending college (−4.89,p=0.03) was the strongest factor associated with ILD, followed by having more lymph nodes removed (4.75,p=0.01), >25% BCRL care adherence (4.10,p=0.01), and years since treatment (0.55,p<0.001).Discussion. Neither race nor BMI was associated with ILD among overweight cancer survivors. Education, a proxy for resource level, was the strongest factor associated with greater ILD. Tailoring physical activity and weight loss interventions designed to address BCRL severity by resource rather than race should be considered.
Multiple Unilateral Vestibular Schwannomas: Segmental NF2 or Sporadic Occurrence?
Carlson, Matthew L. , Van Gompel, Jamie J, Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurological Surgery Reports | June 27, 2016 | Volume: 77 | Issue: 02 | Pages: e106-e108

10.1055/s-0036-1584603 | PMID 27354931 Get It

Cochlear implantation for single‐sided deafness: A multicenter study
Sladen, Douglas P. , Frisch, Christopher D., Carlson, Matthew L. , Driscoll, Colin L. W., Torres, Jennifer H., Zeitler, Daniel M.

Mayo Clinic

The Laryngoscope | June 27, 2016 | Volume: 127 | Issue: 1 | Pages: 223-228

10.1002/lary.26102 | PMID 27346874 Get It

Objectives/HypothesisTo report the preliminary outcomes of patients with single‐sided deafness and asymmetric hearing loss undergoing cochlear implantation at two centers.Study DesignRetrospective review and prospective data collection.MethodsPatients with single‐sided deafness who underwent cochlear implantation at two centers were included. Pre‐ and postoperative measures included monosyllabic word and sentence recognition in quiet for the ear implanted, and sentence recognition in noise in the best‐aided bilateral condition.ResultsAverage monosyllabic word recognition scores in quiet improved significantly from 11.3% (standard deviation [SD] 15.6%) preoperatively to 48.7% (SD 24.2%) at the 3‐month postactivation interval, although they did not increase significantly between the 3‐month and 6‐month intervals. Sentence recognition scores in quiet increased significantly from 18.4% (SD 28.5%) preoperatively to 65.9% (SD 17.9%) at the 3‐month postactivation interval, but not between the 3‐month and 6‐month intervals. Sentence recognition in noise in the best‐aided bilateral condition increased from 59% (SD 16.3%) preoperatively to 72% (SD 16.0%) at 6‐months postactivation, though the difference was not statistically significant. Thirteen of the participants reported tinnitus prior to surgery. Of those, 12 reported that tinnitus was improved after implantation, and one reported that tinnitus was unchanged.ConclusionPreliminary results suggest that speech recognition in a singly deafened ear is significantly improved after cochlear implantation, although speech recognition in noise measured in the bilateral condition remains the same at 6‐months postactivation.Level of Evidence4. Laryngoscope, 127:223–228, 2017
A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma
Han, Ming , Murugesan, Alli , Song, Kevin , White, Darrell , Chen, Christine , Seftel, Matthew D. , Howsen-Jan, Kang, Reece, Donna , Stewart, Keith, Xie, Ya‐Gang, Hay, Annette E. , Shepherd, Lois E. , Djurfeldt, Marina, Zhu, Liting , Meyer, Ralph M., Chen, Bingshu E. , Reiman, Tony , Bahlis, Nizar Jacques , Chen, Bingshu E

Mayo Clinic

Blood | June 25, 2016 | Volume: 128 | Issue: 5 | Pages: 732-735

10.1182/blood-2016-06-716902 | PMID 27338095 Get It

Identification of Senescent Cells in the Bone Microenvironment
Fraser, Daniel G., Wang, Haitao , Jaehn, Katharina, Ogrodnik, Mikołaj , Weivoda, Megan , Tchkonia, Tamar , LeBrasseur, Nathan K. , Kirkland, James L. , Pignolo, Robert J. , Khosla, Sundeep , Wang, Haitao , Farr, Joshua N. , Ogrodnik, Mikolaj B, Weivoda, Megan M, Drake, Matthew T. , Tchkonia, Tamara, Monroe, David G. , Bonewald, Lynda F. , Khosla, Sundeep , Tchkonia, T , LeBrasseur, Nathan K , Wang, Haitao

Mayo Clinic

Journal of Bone and Mineral Research | June 24, 2016 | Volume: 31 | Issue: 11 | Pages: 1920-1929

10.1002/jbmr.2892 | PMID 27341653 Get It

ABSTRACT Cellular senescence is a fundamental mechanism by which cells remain metabolically active yet cease dividing and undergo distinct phenotypic alterations, including upregulation of p16Ink4a, profound secretome changes, telomere shortening, and decondensation of pericentromeric satellite DNA. Because senescent cells accumulate in multiple tissues with aging, these cells and the dysfunctional factors they secrete, termed the senescence-associated secretory phenotype (SASP), are increasingly recognized as promising therapeutic targets to prevent age-related degenerative pathologies, including osteoporosis. However, the cell type(s) within the bone microenvironment that undergoes senescence with aging in vivo has remained poorly understood, largely because previous studies have focused on senescence in cultured cells. Thus in young (age 6 months) and old (age 24 months) mice, we measured senescence and SASP markers in vivo in highly enriched cell populations, all rapidly isolated from bone/marrow without in vitro culture. In both females and males, p16Ink4a expression by real-time quantitative polymerase chain reaction (rt-qPCR) was significantly higher with aging in B cells, T cells, myeloid cells, osteoblast progenitors, osteoblasts, and osteocytes. Further, in vivo quantification of senescence-associated distension of satellites (SADS), ie, large-scale unraveling of pericentromeric satellite DNA, revealed significantly more senescent osteocytes in old compared with young bone cortices (11% versus 2%, p &lt; 0.001). In addition, primary osteocytes from old mice had sixfold more (p &lt; 0.001) telomere dysfunction-induced foci (TIFs) than osteocytes from young mice. Corresponding with the age-associated accumulation of senescent osteocytes was significantly higher expression of multiple SASP markers in osteocytes from old versus young mice, several of which also showed dramatic age-associated upregulation in myeloid cells. These data show that with aging, a subset of cells of various lineages within the bone microenvironment become senescent, although senescent myeloid cells and senescent osteocytes predominantly develop the SASP. Given the critical roles of osteocytes in orchestrating bone remodeling, our findings suggest that senescent osteocytes and their SASP may contribute to age-related bone loss. © 2016 American Society for Bone and Mineral Research
Teflon granulomas mimicking cerebellopontine angle tumors following microvascular decompression
Deep, Nicholas L. , Graffeo, Christopher S. , Copeland, William R., Link, Michael J., Atkinson, John L. D., Neff, Brian A., Raghunathan, Aditya , Carlson, Matthew L. , Atkinson, John L., Link, Michael J. , Raghunathan, Aditya

Mayo Clinic

The Laryngoscope | June 20, 2016 | Volume: 127 | Issue: 3 | Pages: 715-719

10.1002/lary.26126 | PMID 27320780 Get It

Objectives/HypothesisTo report two patients with a history of microvascular decompression (MVD) for hemifacial spasm who presented with Teflon granulomas (TG) mimicking cerebellopontine angle (CPA) tumors and to perform a systematic review of the English‐language literature.Study DesignCase series at a single tertiary academic referral center and systematic review.MethodsRetrospective chart review with analysis of clinical, radiological, and histopathological findings. Systematic review using PubMed, Embase, MEDLINE, and Web of Science databases.ResultsTwo patients with large skull base TGs mimicking CPA tumors clinically and radiographically were managed at the authors' institution. The first presented 4 years after MVD with asymmetrical sensorineural hearing loss, multiple progressive cranial neuropathies, and brainstem edema due to a growing TG. Reoperation with resection of the granuloma confirmed a foreign‐body reaction consisting of multinucleated giant cells containing intracytoplasmic Teflon particles. The second patient presented 11 years after MVD with asymmetrical sensorineural hearing loss and recurrent hemifacial spasm. No growth was noted over 2 years, and the patient has been managed expectantly. Only one prior case of TG after MVD for hemifacial spasm has been reported in the English literature.ConclusionsTG is a rare complication of MVD for hemifacial spasm. The diagnosis should be suspected in patients presenting with a new‐onset enhancing mass of the CPA after MVD, even when performed decades earlier. A thorough clinical and surgical history is critical toward establishing an accurate diagnosis to guide management and prevent unnecessary morbidity. Surgical intervention is not required unless progressive neurologic complications ensue.Level of Evidence4 Laryngoscope, 127:715–719, 2017